| Table 2: Toxicities observed in ten patients treated with adjuvant intraperitoneal pemetrexed combined with intravenous cisplatin following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||